Indianapolis, INNCT05604131Now EnrollingIRB Ready

Acute Myocardial Infarction Type 1 Clinical Trial in Indianapolis, IN

Access cutting-edge acute myocardial infarction type 1 treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Rohan Dharmakumar

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions…

Expert Care in Indianapolis

Access acute myocardial infarction type 1 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute myocardial infarction type 1 treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this acute myocardial infarction type 1 clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Acute Myocardial Infarction Type 1 Study in Indianapolis

The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.

Sponsor: Rohan Dharmakumar

Who Can Participate

Inclusion Criteria

Age 18-79 years
Index Anterior wall STEMI
Emergency coronary angiogram with primary PCI

Exclusion Criteria

Prior history of MI / PCI / coronary artery bypass graft (CABG) within previous 1 year
Patients with previous history of left ventricular ejection fraction (LVEF) \< 40%
Use of investigational drugs or devices 30 days prior to randomization
Known allergy or contra-indication to gadolinium/contrast agents
eGFR \< 30 ml/kg/min
Any contraindication against cardiac MRI (such as metal implants)
Women who are pregnant or breastfeeding. Women of reproductive potential must have a negative pregnancy test prior to randomization
Body weight \> 140 kg (or 309 lbs.)
Absolute neutrophil count - ANC \< 1.5 k/cumm
History of Chronic Liver Disease
Elevated hepatic enzymes (BOTH ALT and AST) \> 2 times of upper normal limit
Patients with iron storage disease (hemochromatosis, thalassemia) or who are already treated with iron chelators
Any clinically significant abnormality identified prior to randomization that in the judgment of the Sponsor-Investigator or Delegate would preclude safe completion of the study or confound the anticipated benefit of deferiprone.
Life expectancy of less than 1 year due to non-cardiac pathology

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT05604131) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Myocardial Infarction Type 1 Treatment Options in Indianapolis, IN

If you're searching for acute myocardial infarction type 1 treatment options in Indianapolis, IN, this clinical trial (NCT05604131) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute myocardial infarction type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute myocardial infarction type 1 clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Indianapolis, IN

See all heart attack clinical trials recruiting in Indianapolis — not just this study.

Browse Heart Attack Trials in Indianapolis →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Embolism TrialsMyocardial Infarction TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN